Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy...
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. The global weight loss drugs market was valued at US$3.83 billion in 2023, and is expected to be worth US$44.12 billion in 2029. The global weight loss drugs market is expected to grow at a CAGR of 49.85% over the years 2024-2029. The market is foreseen to show trajectory growth during the forecasted period due to the development of personalized medicine approaches tailored to individual genetic makeup and metabolism. Additionally, there is a growing interest in natural and herbal weight loss supplements due to their perceived safety and efficacy. The market is also witnessing a shift towards combination therapies and digital health solutions integrating medication with lifestyle modifications and behavioral interventions for more comprehensive weight management. A prominent trend in the weight loss drugs market is the emergence of hig
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- The FTC Cracks Down On Novo Nordisk's Ozempic [Seeking Alpha]Seeking Alpha
- Weight-loss drug competition heats up. Is Wegovy in trouble? [Yahoo! Finance]Yahoo! Finance
- Weight-loss drug competition heats up. Is Wegovy in trouble? [Yahoo! Finance Canada]Yahoo! Finance Canada
- Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide [CNBC]CNBC
- Amgen stock rallies 13% on GLP-1 weight-loss drug update [Seeking Alpha]Seeking Alpha
NVO
Earnings
- 5/2/24 - Beat
NVO
Sec Filings
- 5/2/24 - Form 6-K
- 5/1/24 - Form 6-K
- 4/26/24 - Form 6-K
- NVO's page on the SEC website